期刊文献+

脂联素联合瘦素在结直肠癌高危人群中的诊断价值

Diagnosis Value of Combining Adiponectin and Leptin in High Risk Population with Colorectal Cancer
下载PDF
导出
摘要 目的:探讨脂联素(Adiponectin,ADPN)联合瘦素(Leptin,LP)在结直肠癌高危人群中的诊断价值。方法:选取2016年6月-2017年4月本院收治的结直肠癌患者50例作为A组,于同期另选取50例健康体检者作为B组,测定两组血清ADPN和LP水平,应用受试者工作特征(Receiver Operating Characteristic curve,ROC)曲线分析血清ADPN和LP对结直肠癌的诊断效能。结果:A组血清ADPN水平明显低于B组,差异有统计学意义(P<0.05);A组血清LP水平明显高于B组,差异有统计学意义(P<0.05);ROC曲线显示,两项联合对结直肠癌的敏感度和特异度最高,约登指数和曲线下面积最大。结论:联合检测脂联素联合瘦素有助于提高结直肠癌的检出率。 Objective:To discuss the diagnosis value of combining Adiponectin(ADPN) and Leptin(LP) in high risk population with colorectal cancer.Method:A total of 50 patients with colorectal cancer from June 2016 to April 2017 were selected as A group,and 50 cases of health examiner were selected as B group.The serum levels of ADPN and LP were detected.ROC curve was used to analyze the evaluate the diagnostic efficiency of ADPN combined with LP measured in the study subjects.Result:Serum levels of ADPN in A group was lower than that of B group(P〈0.05).Serum levels of LP in A group was higher than that of B group(P〈0.05).ROC curve showed:the sensitivity,specificity,Youden index and AUC of ADPN+LP was the highest.Conclusion:The combined screening of ADPN and LP can significantly improve the detection rate of colorectal cancer.
作者 彭伟如 冯奕习 梁晶晶 PENG Weiru;FENG Yixi;LIANG Jingjing(The Hospital of Traditional Chinese Medicine in Dongguan City,Dongguan 523000,Chin)
出处 《中国医学创新》 CAS 2018年第21期112-114,共3页 Medical Innovation of China
关键词 脂联素 瘦素 结直肠癌 肿瘤标志物 Adiponectin Leptin Colorectal cancer Tumor marker
  • 相关文献

参考文献14

二级参考文献122

  • 1Sayaka Otake,Hiroaki Takeda,Shoichiro Fujishima,Tadahisa Fukui,Tomohiko Orii,Takeshi Sato,Yu Sasaki,Shoichi Nishise,Sumio Kawata.Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer[J].World Journal of Gastroenterology,2010,16(10):1252-1257. 被引量:14
  • 2王仁辉,温宜清,邓浩财.腹腔镜与开腹结直肠癌根治术的近远期疗效比较[J].消化肿瘤杂志(电子版),2012,4(1):21-25. 被引量:9
  • 3Maka Kekelidze,Luigia D'Errico,Michele Pansini,Anthony Tyndall,Joachim Hohmann.Colorectal cancer:Current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation[J].World Journal of Gastroenterology,2013,19(46):8502-8514. 被引量:29
  • 4Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer [J]. Gut, 2006, 55(2) : 285-291.
  • 5Zhang Y, Proenca R, Mallei M, et al. Positional cloning of the mouse obese gene and its human homologue[J]. Nature, 1994; 372(6505): 425-432.
  • 6Sauter ER, Garofalo C, Hewett J, et al. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer [J].Horm Metab Res, 2004; 36(5):336-340.
  • 7Garofalo C, Surmacz E. Leptin and cancer [J]. J Cell Physiol, 2006, 207(1):12 -22.
  • 8Hardwick JC, Van Den Brink GR, Offerhaus GJ, et al. Leptin is a growth factor for colonic epithelial cells [J]. Gastroenterology, 2001, 121(1): 79-90.
  • 9Aparicio T, Kotelevets L, Tsocas A, etal. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice[J]. Gut, 2005; 54(8): 1136-1145.
  • 10Falk RT, Brinton LA, Madigan MP, et al. Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolaetin and breast cancer risk in young women [J]. Breast Cancer Res Treat, 2006, 98(2): 157-165.

共引文献290

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部